CD19 and primary biliary cholangitis: A study found that PBC patients had significantly higher levels of RANK in cholangiocytes and RANKL in CD4, CD8, and CD19 cells surrounding bile ducts than those with other liver diseases, implying that the RANK-RANKL axis plays a role in the process of bile duct injury.